Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
J Perinatol ; 37(9): 1010-1016, 2017 09.
Article in English | MEDLINE | ID: mdl-28661514

ABSTRACT

OBJECTIVE: To evaluate risk factors and impact of delivery room cardiopulmonary resuscitation (DR-CPR) on very low birth weight (VLBW) preterm infants. STUDY DESIGN: A national, population-based, observational study evaluating risk factors and short-term neonatal outcomes associated with DR-CPR among VLBW, extremely preterm infants (EPIs, 24 to 27 weeks' gestation) and very preterm infants (VPI, 28 to 31 weeks' gestation) born in 1995 to 2010. RESULTS: Among 17 564 VLBW infants, 636 (3.6%) required DR-CPR. In the group of 6478 EPI, 412 (6.4%) received DR-CPR compared with 224 of 11 086 infants (2.0%) in the VPI group. EPI who underwent DR-CPR had higher odds ratios (ORs (95% confidence interval)) for mortality compared to EPI not requiring DR-CPR (OR 3.32 (2.58, 4.29)), grades 3 to 4 intraventricular hemorrhage (IVH) (OR 1.59 (1.20, 2.10)) and periventricular leukomalacia (OR 1.81 (1.17, 2.82)). DR-CPR among VPI was associated with higher ORs for mortality (OR 4.99 (3.59, 6.94)), early sepsis (OR 2.07 (1.05, 4.09)), grades 3 to 4 IVH (OR 3.74 (2.55, 5.50)) and grades 3 to 4 retinopathy of prematurity (ROP) (OR 2.53 (1.18, 5.41)) compared to VPI not requiring DR-CPR. Only 11% of infants in the EPI DR-CPR group had favorable outcomes compared with 44% in the VPI DR-CPR group. Significantly higher ORs for mortality, IVH and ROP were found in the VPI compared to the EPI group. CONCLUSION: Preterm VLBW infants requiring DR-CPR were at increased risk of adverse outcomes compared to those not requiring CPR. This effect was more pronounced in the VPI group.


Subject(s)
Cardiopulmonary Resuscitation/mortality , Delivery Rooms/statistics & numerical data , Infant, Extremely Low Birth Weight , Infant, Extremely Premature , Infant, Premature, Diseases/epidemiology , Adult , Cardiopulmonary Resuscitation/adverse effects , Delivery, Obstetric/statistics & numerical data , Female , Gestational Age , Humans , Infant, Newborn , Logistic Models , Pregnancy , Risk Factors , Treatment Outcome , Young Adult
2.
J Perinatol ; 30(11): 736-40, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20220759

ABSTRACT

OBJECTIVE: To reassess iron supplementation practice safety in very low birth weight (VLBW) preterm infants receiving restrictive red blood cell transfusions during initial hospitalization. STUDY DESIGN: Iron status, including hemoglobin (Hb), serum iron, ferritin, and soluble transferrin receptor (sTfR) levels and reticulocyte count of transfused (n=236) and non-transfused (n=166) preterm infants at ≤24 h and 2, 4 and 8 weeks were recorded. As per protocol, a restrictive blood transfusion policy and supplementation of 5 mg kg(-1) per day of iron polymaltose complex from 4 weeks and 25 mg(-1) per day of vitamin E from 2 weeks were imposed for all infants. Normative reference cord-blood ferritin value of preterm infants was used for comparison. Vitamin E levels and incidence of morbidities associated with prematurity were recorded. RESULT: At ≤24 h, the characteristics and iron status of both groups were similar. At 2, 4 and 8 weeks, the transfused group had significantly higher Hb, iron and ferritin levels; sTfR levels were lower at 4 and 8 weeks (all indices, P<0.05). At 8 weeks, the median ferritin levels of our transfused group were lower than that of normative reference cord-blood value (115 (50th percentile) vs 79 (43 to 107) µg l(-1), respectively). Vitamin E levels and the incidence of morbidities associated with prematurity of the transfused and non-transfused groups were not different (both indices, P>0.18). CONCLUSION: Adding iron supplementation to preterm infants receiving restrictive blood transfusions has shown to be a judicious and safe practice in terms of iron status for VLBW preterm infants.


Subject(s)
Biomarkers, Pharmacological/blood , Erythrocyte Transfusion/adverse effects , Infant Nutritional Physiological Phenomena/drug effects , Infant, Premature , Iron , Follow-Up Studies , Humans , Infant, Newborn , Infant, Premature/blood , Infant, Premature/growth & development , Infant, Very Low Birth Weight/blood , Infant, Very Low Birth Weight/growth & development , Iron/administration & dosage , Iron/adverse effects , Iron/metabolism , Nutrition Assessment , Nutritional Status/drug effects , Trace Elements/administration & dosage , Trace Elements/adverse effects , Trace Elements/metabolism , Vitamin E/administration & dosage , Vitamin E/adverse effects , Vitamin E/metabolism , Vitamins/administration & dosage , Vitamins/adverse effects , Vitamins/metabolism
3.
J Perinatol ; 29(8): 585-7, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19638993

ABSTRACT

Meconium periorchitis (MP) is a rare disorder caused by fetal meconium peritonitis with subsequent spillage of meconium into the scrotal sac. The condition is seldom diagnosed correctly during fetal life and the ultrasonographic diagnoses reported vary from no diagnosis to hematoma or hydrocele. It is usually diagnosed clinically during the first year of life when a scrotal mass is an incidental finding. Here, we describe two cases of MP that were diagnosed during routine intrauterine ultrasound examination for fetal growth assessment, and confirmed after birth. One infant underwent a surgical excision of the scrotal mass, confirming the histological diagnosis of meconium periorchitis. The other was managed conservatively. Neither had cystic fibrosis. Thus, we believe that a diagnosis of MP should be considered when prenatal ultrasonographic findings are suspicious for the problem. The awareness of the ultrasonographer and the neonatologist are important for immediate postnatal management, as congenital scrotal masses may have other etiologies.


Subject(s)
Fetal Diseases/diagnostic imaging , Meconium/diagnostic imaging , Orchitis/diagnostic imaging , Testicular Hydrocele/diagnostic imaging , Ultrasonography, Prenatal , Female , Humans , Infant, Newborn , Male , Pregnancy
4.
J Perinatol ; 27(5): 297-302, 2007 May.
Article in English | MEDLINE | ID: mdl-17344924

ABSTRACT

OBJECTIVES: To evaluate the accuracy of serum amyloid A (SAA), an acute phase protein in the detection of neonatal early-onset sepsis, by means of a fast automated SAA kit. STUDY DESIGN: Full-term infants <72 h of age, who had risk factors and/or were suspected of having sepsis, were eligible for study. The levels of SAA were taken at 0, 24 and 48 h post sepsis evaluation. Thirty matched infants served as a control group for comparing SAA concentrations. RESULTS: Of 104 infants eligible for entry to the study, 23 had sepsis and 81 had not sepsis. The SAA levels of the septic group were significantly higher than those of the nonseptic group at 0, 24 and 48 h (P<0.01 for all time points). In comparison with C-reactive protein (CRP), SAA levels rose earlier and in a sharper manner, had higher levels and returned faster to normal values in infants with early onset sepsis. At 0 h post-sepsis evaluation, serum SAA had an overall better diagnostic accuracy for predicting early onset sepsis than CRP (sensitivity (96 vs 30%), specificity (95 vs 98%), positive predictive value (85 vs 78%), negative predictive value (99 vs 83%), positive likelihood ratio (19 vs 12), and negative likelihood ratio (0.05 vs 0.71). CONCLUSIONS: SSA is advocated as an inflammatory marker of neonatal early-onset sepsis.


Subject(s)
Escherichia coli Infections/diagnosis , Infant, Newborn, Diseases/diagnosis , Serum Amyloid A Protein/metabolism , Staphylococcal Infections/diagnosis , Streptococcal Infections/diagnosis , Streptococcus agalactiae , Biomarkers/blood , C-Reactive Protein/metabolism , Early Diagnosis , Escherichia coli Infections/blood , Female , Humans , Infant, Newborn , Infant, Newborn, Diseases/blood , Male , Predictive Value of Tests , Reference Values , Risk Factors , Sepsis/blood , Sepsis/diagnosis , Staphylococcal Infections/blood , Streptococcal Infections/blood
5.
Calcif Tissue Int ; 80(1): 39-43, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17164971

ABSTRACT

Studies have previously demonstrated that brief (4 weeks) passive range-of-motion exercise is beneficial for bone development in very low birth weight (VLBW) preterm infants. However, the optimal duration of exercise for bone development in preterm infants is yet unknown. The aim of the present study was to examine the effect of 8 weeks of assisted exercise on bone strength and metabolism in VLBW premature infants. Sixteen infants (mean +/- standard error of the mean birth weight 1,009 +/- 55 g and gestational age 27.3 +/- 0.3 weeks) were randomly assigned into exercise (n = 8) and control (n = 8) groups. The intervention started at the first week of life and involved 8 weeks of daily passive extension and flexion range-of-motion exercise of the upper and lower extremities. Biochemical markers of bone turnover were measured at enrollment and after 8 weeks. Bone strength was measured weekly by quantitative ultrasound measurement of tibial bone speed of sound (SOS). Bone SOS decreased significantly in the control group (-108.1 +/- 33.7 m/second, P < 0.0001) during the study period, while remaining stable in the exercise group (11.3 +/- 22.8 m/second). The main beneficial effect of exercise occurred in the first 4 weeks of the intervention. There were no significant differences in the bone turnover marker changes between the groups. There is a significant postnatal decrease in bone SOS in VLBW preterm infants. Eight weeks of assisted range-of-motion exercise attenuates the decrease in bone strength and may decrease the risk of osteopenia in premature infants.


Subject(s)
Bone Density/physiology , Exercise/physiology , Infant, Premature/physiology , Infant, Very Low Birth Weight/physiology , Body Weight/physiology , Bone Diseases, Metabolic/etiology , Bone Diseases, Metabolic/prevention & control , Bone and Bones/metabolism , Female , Humans , Infant, Newborn , Male , Range of Motion, Articular/physiology , Risk Factors
7.
J Perinat Med ; 28(2): 158-60, 2000.
Article in English | MEDLINE | ID: mdl-10875104

ABSTRACT

Reported herein are the cases of three infants who were born with serious intrathoracic injuries, apparently sustained at the time of the mother's involvement in a motor vehicle accident. The accidents occurred at 26th, 29th and 36th weeks of pregnancy and resulted in minimal injuries to the mothers themselves. The infants were born four weeks, three hours and two days later, respectively. Their injuries were manifested (singly) by hemothorax, pneumothorax and contusion of lung, the latter in a setting of multi-organ trauma. We suggest that chest x-ray, in addition to brain ultrasound, be routinely included in the evaluation of neonates whose mothers were involved in a motor vehicle accident during pregnancy, not excluding cases wherein the mother's injuries were negligible or inapparent and regardless of the time elapsed between accident and delivery.


Subject(s)
Accidents, Traffic , Lung Injury , Thorax/embryology , Adult , Brain Diseases/diagnostic imaging , Brain Diseases/etiology , Contusions/diagnosis , Contusions/etiology , Drainage , Female , Hemothorax/diagnosis , Hemothorax/etiology , Hemothorax/surgery , Humans , Infant, Newborn , Infant, Premature , Labor, Induced , Male , Pneumothorax/diagnosis , Pneumothorax/etiology , Pneumothorax/surgery , Pregnancy , Radiography , Respiration, Artificial , Respiratory Distress Syndrome, Newborn/diagnostic imaging , Respiratory Distress Syndrome, Newborn/etiology , Respiratory Distress Syndrome, Newborn/therapy , Ultrasonography
8.
Acta Paediatr ; 85(4): 514-5, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8740318

ABSTRACT

Infants suffering from congenital heart anomalies who are receiving intravenous prostaglandins may present with gastric outlet obstruction. We describe a newborn with tetralogy of Fallot who was not being treated with prostaglandins and presented with gastric outlet obstruction. The typical clinical and radiological signs of infantile hypertrophic pyloric stenosis resolved spontaneously within several days. We suggest that there may be an association between cyanotic heart disease and gastric outlet obstruction unrelated to the use of prostaglandins.


Subject(s)
Abnormalities, Multiple , Gastric Outlet Obstruction/congenital , Pyloric Stenosis/congenital , Tetralogy of Fallot/complications , Abnormalities, Multiple/diagnostic imaging , Barium Sulfate , Gastric Outlet Obstruction/diagnostic imaging , Humans , Hypertrophy , Infant, Newborn , Male , Pyloric Stenosis/diagnostic imaging , Radiography
9.
Acta Paediatr ; 84(5): 585-7, 1995 May.
Article in English | MEDLINE | ID: mdl-7633161

ABSTRACT

We report a premature infant with Staphylococcus aureus sepsis, most probably originating from an infected peripheral iv site, and complicated by multiple brain abscesses. Diagnosis was made by cranial ultrasonography and computed tomography. Since systemic antibiotic treatment failed, surgical drainage was performed. The same organism that caused the initial sepsis grew from the pyogenic material obtained. The child is currently severely handicapped.


Subject(s)
Brain Abscess/etiology , Infant, Premature, Diseases/etiology , Sepsis/complications , Staphylococcal Infections/complications , Brain Abscess/diagnostic imaging , Brain Abscess/microbiology , Echoencephalography , Humans , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/diagnostic imaging , Infant, Premature, Diseases/microbiology , Infusions, Intravenous/adverse effects , Male
10.
J Perinat Med ; 19(3): 173-6, 1991.
Article in English | MEDLINE | ID: mdl-1748938

ABSTRACT

Indomethacin has been used in twins with polyhydramnios to decrease amniotic fluid volume. Under therapy, a marked reduction of both fetuses' urine production has been demonstrated within 24 hours concomitant with maternal symptomatic relief. Discontinuation of therapy was associated with a rapid increase in fetal urine production. The clinical observation indicates that the benefit of indomethacin in prolonging such pregnancies is most probably the result of relief of polyhydramnios through decreased fetal urine production.


Subject(s)
Fetus/physiology , Indomethacin/therapeutic use , Polyhydramnios/drug therapy , Pregnancy, Multiple , Urination/drug effects , Administration, Oral , Administration, Rectal , Adult , Amniotic Fluid/drug effects , Female , Humans , Indomethacin/adverse effects , Polyhydramnios/urine , Pregnancy , Suppositories
SELECTION OF CITATIONS
SEARCH DETAIL